United States Healthcare Equipment & Supplies

Artivion Inc (AORT)

Track

Track

Artivion Inc. experienced significant insider selling activity over the past ninety days, totaling approximately 4.9 million dollars. Executives, including James P. Mackin, offloaded shares following the August 6th results financiers. These divestments occurred amid a 28.3% stock price appreciation, reflecting ongoing liquidity events by corporate leadership during this period of market performance.
Ticker: AORT Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Artivion Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.6
Mackin James P Officer Officer
Transaction date
Proposed sale
Price
143.30
Quantity 99,155
Value US$2,582,405
1.5
GREEN ANDREW M SVP, Regulatory and Quality Officer
Transaction date
Sale
Price
369.26
Quantity 70,591 -39.8%
Value US$2,077,654
2.9
Berry Lance A EVP, COO, CFO & Treasurer Officer
Transaction date
Sale
Price
319.09
Quantity 894 -15.2%
Value US$4,266,716
2.9
Berry Lance A Officer Officer
Transaction date
Proposed sale
Price
28.55
Quantity 1,000
Value US$100,000
1.5
GREEN ANDREW M Officer Officer
Transaction date
Proposed sale
Price
28.55
Quantity 1,000
Value US$100,000
3.6
Holloway Jean F SVP, General Counsel Officer
Transaction date
Sale
Price
28.49
Quantity 1,000 -0.5%
Value US$100,000
1.5
GREEN ANDREW M SVP, Regulatory and Quality Officer
Transaction date
Planned sale
Price
20.69
Quantity 30,000 -33.2%
Value US$620,820
1.5
GREEN ANDREW M SVP, Regulatory and Quality Officer
Transaction date
Planned sale
Price
20.71
Quantity 14,001 -18.9%
Value US$289,919
1.5
GREEN ANDREW M Officer Officer
Transaction date
Proposed sale
Price
20.70
Quantity 44,001
Value US$910,753
1.5
GREEN ANDREW M Officer Officer
Transaction date
Proposed sale
Price
20.70
Quantity 44,001
Value US$910,753
3.6
Holloway Jean F SVP, General Counsel Officer
Transaction date
Sale
Price
38.00
Quantity 8,962 -4.6%
Value US$340,556
3.6
JEAN F HOLLOWAY Officer Officer
Transaction date
Proposed sale
Price
38.00
Quantity 8,962
Value US$340,556
3.5
Horton Amy VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
37.78
Quantity 901 -0.6%
Value US$34,036
3.6
Holloway Jean F SVP, General Counsel Officer
Transaction date
Sale
Price
37.78
Quantity 3,843 -1.9%
Value US$145,172
3.4
Stanton Marshall S. SVP, Clinical & MD Affair Officer
Transaction date
Sale
Price
37.78
Quantity 2,149 -3.5%
Value US$81,180
3.4
Davis John E Chief Commercial Officer Officer
Transaction date
Sale
Price
37.78
Quantity 4,573 -1.9%
Value US$172,748
2.9
Berry Lance A EVP, COO, CFO & Treasurer Officer
Transaction date
Sale
Price
37.78
Quantity 6,316 -2.9%
Value US$238,591
3.6
Mackin James P President & CEO Officer
Transaction date
Sale
Price
37.78
Quantity 17,887 -1.9%
Value US$675,692
3.6
Holloway Jean F Officer Officer
Transaction date
Proposed sale
Price
37.78
Quantity 3,843
Value US$145,172
2.9
Berry Lance A Officer Officer
Transaction date
Proposed sale
Price
37.78
Quantity 6,316
Value US$238,591
3.4
Davis John E Officer Officer
Transaction date
Proposed sale
Price
37.78
Quantity 4,573
Value US$172,748
3.4
Stanton Marshall S. Officer Officer
Transaction date
Proposed sale
Price
37.78
Quantity 2,149
Value US$81,180
3.6
Mackin James P Officer; Director Executive Director
Transaction date
Proposed sale
Price
37.78
Quantity 17,887
Value US$675,692
3.5
Horton Amy Officer Officer
Transaction date
Proposed sale
Price
37.78
Quantity 901
Value US$34,036
3.5
Horton Amy VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
38.02
Quantity 641 -0.5%
Value US$24,374
3.4
Stanton Marshall S. SVP, Clinical & MD Affair Officer
Transaction date
Sale
Price
38.02
Quantity 1,513 -3.6%
Value US$57,532
3.6
Mackin James P President & CEO Officer
Transaction date
Sale
Price
38.02
Quantity 14,911 -1.7%
Value US$566,989
3.6
Holloway Jean F SVP, General Counsel Officer
Transaction date
Sale
Price
38.02
Quantity 2,183 -1.3%
Value US$83,008
2.9
Berry Lance A EVP, COO, CFO & Treasurer Officer
Transaction date
Sale
Price
38.02
Quantity 5,178 -2.9%
Value US$196,893
3.4
Davis John E Chief Commercial Officer Officer
Transaction date
Sale
Price
38.02
Quantity 2,784 -1.3%
Value US$105,861
3.6
Holloway Jean F Officer Officer
Transaction date
Proposed sale
Price
38.02
Quantity 2,183
Value US$83,008
3.6
Mackin James P Officer; Director Executive Director
Transaction date
Proposed sale
Price
38.02
Quantity 14,911
Value US$566,989
3.4
Davis John E Officer Officer
Transaction date
Proposed sale
Price
38.02
Quantity 2,784
Value US$105,861
2.9
Berry Lance A Officer Officer
Transaction date
Proposed sale
Price
38.02
Quantity 5,178
Value US$196,893
3.5
Horton Amy Officer Officer
Transaction date
Proposed sale
Price
38.02
Quantity 641
Value US$24,374
3.4
Stanton Marshall S. Officer Officer
Transaction date
Proposed sale
Price
38.02
Quantity 1,513
Value US$57,532
3.5
Horton Amy VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
35.69
Quantity 830 -0.6%
Value US$29,625
3.6
Holloway Jean F SVP, General Counsel Officer
Transaction date
Sale
Price
35.69
Quantity 1,668 -1.1%
Value US$59,536
3.4
Stanton Marshall S. SVP, Clinical & MD Affair Officer
Transaction date
Sale
Price
35.69
Quantity 1,259 -2.9%
Value US$44,937
3.6
Mackin James P President & CEO Officer
Transaction date
Sale
Price
35.69
Quantity 13,936 -1.8%
Value US$497,418
2.9
Berry Lance A EVP, COO, CFO & Treasurer Officer
Transaction date
Sale
Price
35.69
Quantity 4,485 -3.0%
Value US$160,083
3.4
Davis John E Chief Commercial Officer Officer
Transaction date
Sale
Price
35.69
Quantity 2,075 -1.1%
Value US$74,063
3.4
Davis John E Officer Officer
Transaction date
Proposed sale
Price
35.69
Quantity 2,075
Value US$74,063
2.9
Berry Lance A Officer Officer
Transaction date
Proposed sale
Price
35.69
Quantity 4,485
Value US$160,083
3.6
Holloway Jean F Officer Officer
Transaction date
Proposed sale
Price
35.69
Quantity 1,668
Value US$59,536
3.6
Mackin James P Officer; Director Executive Director
Transaction date
Proposed sale
Price
35.69
Quantity 13,936
Value US$497,416
3.4
Stanton Marshall S. Officer Officer
Transaction date
Proposed sale
Price
35.69
Quantity 1,259
Value US$44,937
3.5
Horton Amy Officer Officer
Transaction date
Proposed sale
Price
35.69
Quantity 830
Value US$29,625
3.5
Horton Amy VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
37.59
Quantity 1,731 -1.3%
Value US$65,065
3.6
Holloway Jean F SVP, General Counsel Officer
Transaction date
Sale
Price
37.59
Quantity 3,079 -2.0%
Value US$115,733
3.4
Stanton Marshall S. SVP, Clinical & MD Affair Officer
Transaction date
Sale
Price
37.59
Quantity 2,423 -5.3%
Value US$91,076
3.6
Mackin James P President & CEO Officer
Transaction date
Sale
Price
37.59
Quantity 20,962 -2.6%
Value US$787,920
2.9
Berry Lance A EVP, COO, CFO & Treasurer Officer
Transaction date
Sale
Price
37.59
Quantity 4,981 -3.2%
Value US$187,226
3.4
Davis John E Chief Commercial Officer Officer
Transaction date
Sale
Price
37.59
Quantity 3,773 -1.9%
Value US$141,820
3.5
Horton Amy Officer Officer
Transaction date
Proposed sale
Price
37.59
Quantity 1,731
Value US$65,064
3.6
Mackin James P Officer; Director Executive Director
Transaction date
Proposed sale
Price
37.59
Quantity 20,962
Value US$787,909
3.4
Davis John E Officer Officer
Transaction date
Proposed sale
Price
37.59
Quantity 3,773
Value US$141,818
3.6
Holloway Jean F Officer Officer
Transaction date
Proposed sale
Price
37.59
Quantity 3,079
Value US$115,732
2.9
Berry Lance A Officer Officer
Transaction date
Proposed sale
Price
37.59
Quantity 4,981
Value US$187,223
3.4
Stanton Marshall S. Officer Officer
Transaction date
Proposed sale
Price
37.59
Quantity 2,423
Value US$91,075
3.4
Davis John E Officer Officer
Transaction date
Proposed sale
Price
45.11
Quantity 5,000
Value US$225,554
3.4
Davis John E Chief Commercial Officer Officer
Transaction date
Sale
Price
45.11
Quantity 5,000 -2.5%
Value US$225,550
3.5
Horton Amy VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
44.42
Quantity 4,572 -3.4%
Value US$203,084
3.5
Horton Amy Officer Officer
Transaction date
Proposed sale
Price
44.42
Quantity 4,572
Value US$203,081
3.6
Mackin James P President & CEO Officer
Transaction date
Planned sale
Price
45.46
Quantity 30,921 -3.7%
Value US$1,405,700
3.6
Holloway Jean F SVP, General Counsel Officer
Transaction date
Sale
Price
45.30
Quantity 5,267 -3.3%
Value US$238,595
3.6
Holloway Jean F SVP, General Counsel Officer
Transaction date
Sale
Price
45.30
Quantity 2,048 -1.3%
Value US$92,774
3.6
Mackin James P Officer; Director Executive Director
Transaction date
Proposed sale
Price
45.46
Quantity 30,921
Value US$1,405,695
3.6
JEAN F HOLLOWAY Officer Officer
Transaction date
Proposed sale
Price
45.30
Quantity 7,315
Value US$331,391
3.6
Mackin James P President & CEO Officer
Transaction date
Planned sale
Price
45.56
Quantity 30,921 -3.7%
Value US$1,408,730
3.6
Mackin James P Officer; Director Executive Director
Transaction date
Proposed sale
Price
46.27
Quantity 30,921
Value US$1,430,715
3.4
Stanton Marshall S. SVP, Clinical & MD Affair Officer
Transaction date
Sale
Price
45.35
Quantity 8,370 -15.8%
Value US$379,538
3.4
Stanton Marshall S. SVP, Clinical & MD Affair Officer
Transaction date
Sale
Price
44.91
Quantity 18,705 -26.0%
Value US$840,042
3.4
Stanton Marshall S. SVP, Clinical & MD Affair Officer
Transaction date
Sale
Price
45.35
Quantity 5,715 -11.3%
Value US$259,152
3.4
Stanton Marshall S. SVP, Clinical & MD Affair Officer
Transaction date
Sale
Price
44.92
Quantity 14,586 -22.4%
Value US$655,189
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-19 2026-08-19 PrS Proposed sale
3.6
Mackin James P

Officer

Officer
99,155
143.30
US$2,582,405 		99,155 143.30 US$2,582,405
2026-08-17 2026-08-14 S Sale
1.5
GREEN ANDREW M

SVP, Regulatory and Quality

Officer
70,591 -39.8%
369.26
US$2,077,654 		70,591 -39.8% 369.26 US$2,077,654
2026-08-17 2026-08-14 S Sale
2.9
Berry Lance A

EVP, COO, CFO & Treasurer

Officer
894 -15.2%
319.09
US$4,266,716 		894 -15.2% 319.09 US$4,266,716
2026-08-14 2026-08-14 PrS Proposed sale
2.9
Berry Lance A

Officer

Officer
1,000
28.55
US$100,000 		1,000 28.55 US$100,000
2026-08-14 2026-08-14 PrS Proposed sale
1.5
GREEN ANDREW M

Officer

Officer
1,000
28.55
US$100,000 		1,000 28.55 US$100,000
2026-08-12 2026-08-12 S Sale
3.6
Holloway Jean F

SVP, General Counsel

Officer
1,000 -0.5%
28.49
US$100,000 		1,000 -0.5% 28.49 US$100,000
2026-06-15 2026-06-11 PlS Planned sale
1.5
GREEN ANDREW M

SVP, Regulatory and Quality

Officer
30,000 -33.2%
20.69
US$620,820 		30,000 -33.2% 20.69 US$620,820
2026-06-15 2026-06-11 PlS Planned sale
1.5
GREEN ANDREW M

SVP, Regulatory and Quality

Officer
14,001 -18.9%
20.71
US$289,919 		14,001 -18.9% 20.71 US$289,919
2026-06-11 2026-06-11 PrS Proposed sale
1.5
GREEN ANDREW M

Officer

Officer
44,001
20.70
US$910,753 		44,001 20.70 US$910,753
2026-06-11 2026-06-11 PrS Proposed sale
1.5
GREEN ANDREW M

Officer

Officer
44,001
20.70
US$910,753 		44,001 20.70 US$910,753
2026-03-04 2026-03-04 S Sale
3.6
Holloway Jean F

SVP, General Counsel

Officer
8,962 -4.6%
38.00
US$340,556 		8,962 -4.6% 38.00 US$340,556
2026-03-04 2026-03-04 PrS Proposed sale
3.6
JEAN F HOLLOWAY

Officer

Officer
8,962
38.00
US$340,556 		8,962 38.00 US$340,556
2026-03-04 2026-03-03 S Sale
3.5
Horton Amy

VP, Chief Accounting Officer

Officer
901 -0.6%
37.78
US$34,036 		901 -0.6% 37.78 US$34,036
2026-03-04 2026-03-03 S Sale
3.6
Holloway Jean F

SVP, General Counsel

Officer
3,843 -1.9%
37.78
US$145,172 		3,843 -1.9% 37.78 US$145,172
2026-03-04 2026-03-03 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
2,149 -3.5%
37.78
US$81,180 		2,149 -3.5% 37.78 US$81,180
2026-03-04 2026-03-03 S Sale
3.4
Davis John E

Chief Commercial Officer

Officer
4,573 -1.9%
37.78
US$172,748 		4,573 -1.9% 37.78 US$172,748
2026-03-04 2026-03-03 S Sale
2.9
Berry Lance A

EVP, COO, CFO & Treasurer

Officer
6,316 -2.9%
37.78
US$238,591 		6,316 -2.9% 37.78 US$238,591
2026-03-04 2026-03-03 S Sale
3.6
Mackin James P

President & CEO

Officer
17,887 -1.9%
37.78
US$675,692 		17,887 -1.9% 37.78 US$675,692
2026-03-03 2026-03-03 PrS Proposed sale
3.6
Holloway Jean F

Officer

Officer
3,843
37.78
US$145,172 		3,843 37.78 US$145,172
2026-03-03 2026-03-03 PrS Proposed sale
2.9
Berry Lance A

Officer

Officer
6,316
37.78
US$238,591 		6,316 37.78 US$238,591
2026-03-03 2026-03-03 PrS Proposed sale
3.4
Davis John E

Officer

Officer
4,573
37.78
US$172,748 		4,573 37.78 US$172,748
2026-03-03 2026-03-03 PrS Proposed sale
3.4
Stanton Marshall S.

Officer

Officer
2,149
37.78
US$81,180 		2,149 37.78 US$81,180
2026-03-03 2026-03-03 PrS Proposed sale
3.6
Mackin James P

Officer; Director

Executive Director
17,887
37.78
US$675,692 		17,887 37.78 US$675,692
2026-03-03 2026-03-03 PrS Proposed sale
3.5
Horton Amy

Officer

Officer
901
37.78
US$34,036 		901 37.78 US$34,036
2026-03-03 2026-03-02 S Sale
3.5
Horton Amy

VP, Chief Accounting Officer

Officer
641 -0.5%
38.02
US$24,374 		641 -0.5% 38.02 US$24,374
2026-03-03 2026-03-02 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
1,513 -3.6%
38.02
US$57,532 		1,513 -3.6% 38.02 US$57,532
2026-03-03 2026-03-02 S Sale
3.6
Mackin James P

President & CEO

Officer
14,911 -1.7%
38.02
US$566,989 		14,911 -1.7% 38.02 US$566,989
2026-03-03 2026-03-02 S Sale
3.6
Holloway Jean F

SVP, General Counsel

Officer
2,183 -1.3%
38.02
US$83,008 		2,183 -1.3% 38.02 US$83,008
2026-03-03 2026-03-02 S Sale
2.9
Berry Lance A

EVP, COO, CFO & Treasurer

Officer
5,178 -2.9%
38.02
US$196,893 		5,178 -2.9% 38.02 US$196,893
2026-03-03 2026-03-02 S Sale
3.4
Davis John E

Chief Commercial Officer

Officer
2,784 -1.3%
38.02
US$105,861 		2,784 -1.3% 38.02 US$105,861
2026-03-02 2026-03-02 PrS Proposed sale
3.6
Holloway Jean F

Officer

Officer
2,183
38.02
US$83,008 		2,183 38.02 US$83,008
2026-03-02 2026-03-02 PrS Proposed sale
3.6
Mackin James P

Officer; Director

Executive Director
14,911
38.02
US$566,989 		14,911 38.02 US$566,989
2026-03-02 2026-03-02 PrS Proposed sale
3.4
Davis John E

Officer

Officer
2,784
38.02
US$105,861 		2,784 38.02 US$105,861
2026-03-02 2026-03-02 PrS Proposed sale
2.9
Berry Lance A

Officer

Officer
5,178
38.02
US$196,893 		5,178 38.02 US$196,893
2026-03-02 2026-03-02 PrS Proposed sale
3.5
Horton Amy

Officer

Officer
641
38.02
US$24,374 		641 38.02 US$24,374
2026-03-02 2026-03-02 PrS Proposed sale
3.4
Stanton Marshall S.

Officer

Officer
1,513
38.02
US$57,532 		1,513 38.02 US$57,532
2026-02-25 2026-02-24 S Sale
3.5
Horton Amy

VP, Chief Accounting Officer

Officer
830 -0.6%
35.69
US$29,625 		830 -0.6% 35.69 US$29,625
2026-02-25 2026-02-24 S Sale
3.6
Holloway Jean F

SVP, General Counsel

Officer
1,668 -1.1%
35.69
US$59,536 		1,668 -1.1% 35.69 US$59,536
2026-02-25 2026-02-24 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
1,259 -2.9%
35.69
US$44,937 		1,259 -2.9% 35.69 US$44,937
2026-02-25 2026-02-24 S Sale
3.6
Mackin James P

President & CEO

Officer
13,936 -1.8%
35.69
US$497,418 		13,936 -1.8% 35.69 US$497,418
2026-02-25 2026-02-24 S Sale
2.9
Berry Lance A

EVP, COO, CFO & Treasurer

Officer
4,485 -3.0%
35.69
US$160,083 		4,485 -3.0% 35.69 US$160,083
2026-02-25 2026-02-24 S Sale
3.4
Davis John E

Chief Commercial Officer

Officer
2,075 -1.1%
35.69
US$74,063 		2,075 -1.1% 35.69 US$74,063
2026-02-24 2026-02-24 PrS Proposed sale
3.4
Davis John E

Officer

Officer
2,075
35.69
US$74,063 		2,075 35.69 US$74,063
2026-02-24 2026-02-24 PrS Proposed sale
2.9
Berry Lance A

Officer

Officer
4,485
35.69
US$160,083 		4,485 35.69 US$160,083
2026-02-24 2026-02-24 PrS Proposed sale
3.6
Holloway Jean F

Officer

Officer
1,668
35.69
US$59,536 		1,668 35.69 US$59,536
2026-02-24 2026-02-24 PrS Proposed sale
3.6
Mackin James P

Officer; Director

Executive Director
13,936
35.69
US$497,416 		13,936 35.69 US$497,416
2026-02-24 2026-02-24 PrS Proposed sale
3.4
Stanton Marshall S.

Officer

Officer
1,259
35.69
US$44,937 		1,259 35.69 US$44,937
2026-02-24 2026-02-24 PrS Proposed sale
3.5
Horton Amy

Officer

Officer
830
35.69
US$29,625 		830 35.69 US$29,625
2026-02-25 2026-02-23 S Sale
3.5
Horton Amy

VP, Chief Accounting Officer

Officer
1,731 -1.3%
37.59
US$65,065 		1,731 -1.3% 37.59 US$65,065
2026-02-25 2026-02-23 S Sale
3.6
Holloway Jean F

SVP, General Counsel

Officer
3,079 -2.0%
37.59
US$115,733 		3,079 -2.0% 37.59 US$115,733
2026-02-25 2026-02-23 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
2,423 -5.3%
37.59
US$91,076 		2,423 -5.3% 37.59 US$91,076
2026-02-25 2026-02-23 S Sale
3.6
Mackin James P

President & CEO

Officer
20,962 -2.6%
37.59
US$787,920 		20,962 -2.6% 37.59 US$787,920
2026-02-25 2026-02-23 S Sale
2.9
Berry Lance A

EVP, COO, CFO & Treasurer

Officer
4,981 -3.2%
37.59
US$187,226 		4,981 -3.2% 37.59 US$187,226
2026-02-25 2026-02-23 S Sale
3.4
Davis John E

Chief Commercial Officer

Officer
3,773 -1.9%
37.59
US$141,820 		3,773 -1.9% 37.59 US$141,820
2026-02-23 2026-02-23 PrS Proposed sale
3.5
Horton Amy

Officer

Officer
1,731
37.59
US$65,064 		1,731 37.59 US$65,064
2026-02-23 2026-02-23 PrS Proposed sale
3.6
Mackin James P

Officer; Director

Executive Director
20,962
37.59
US$787,909 		20,962 37.59 US$787,909
2026-02-23 2026-02-23 PrS Proposed sale
3.4
Davis John E

Officer

Officer
3,773
37.59
US$141,818 		3,773 37.59 US$141,818
2026-02-23 2026-02-23 PrS Proposed sale
3.6
Holloway Jean F

Officer

Officer
3,079
37.59
US$115,732 		3,079 37.59 US$115,732
2026-02-23 2026-02-23 PrS Proposed sale
2.9
Berry Lance A

Officer

Officer
4,981
37.59
US$187,223 		4,981 37.59 US$187,223
2026-02-23 2026-02-23 PrS Proposed sale
3.4
Stanton Marshall S.

Officer

Officer
2,423
37.59
US$91,075 		2,423 37.59 US$91,075
2025-12-17 2025-12-15 PrS Proposed sale
3.4
Davis John E

Officer

Officer
5,000
45.11
US$225,554 		5,000 45.11 US$225,554
2025-12-17 2025-12-15 S Sale
3.4
Davis John E

Chief Commercial Officer

Officer
5,000 -2.5%
45.11
US$225,550 		5,000 -2.5% 45.11 US$225,550
2025-12-09 2025-12-08 S Sale
3.5
Horton Amy

VP, Chief Accounting Officer

Officer
4,572 -3.4%
44.42
US$203,084 		4,572 -3.4% 44.42 US$203,084
2025-12-08 2025-12-08 PrS Proposed sale
3.5
Horton Amy

Officer

Officer
4,572
44.42
US$203,081 		4,572 44.42 US$203,081
2025-12-04 2025-12-03 PlS Planned sale
3.6
Mackin James P

President & CEO

Officer
30,921 -3.7%
45.46
US$1,405,700 		30,921 -3.7% 45.46 US$1,405,700
2025-12-04 2025-12-03 S Sale
3.6
Holloway Jean F

SVP, General Counsel

Officer
5,267 -3.3%
45.30
US$238,595 		5,267 -3.3% 45.30 US$238,595
2025-12-04 2025-12-03 S Sale
3.6
Holloway Jean F

SVP, General Counsel

Officer
2,048 -1.3%
45.30
US$92,774 		2,048 -1.3% 45.30 US$92,774
2025-12-03 2025-12-03 PrS Proposed sale
3.6
Mackin James P

Officer; Director

Executive Director
30,921
45.46
US$1,405,695 		30,921 45.46 US$1,405,695
2025-12-03 2025-12-03 PrS Proposed sale
3.6
JEAN F HOLLOWAY

Officer

Officer
7,315
45.30
US$331,391 		7,315 45.30 US$331,391
2025-12-03 2025-12-02 PlS Planned sale
3.6
Mackin James P

President & CEO

Officer
30,921 -3.7%
45.56
US$1,408,730 		30,921 -3.7% 45.56 US$1,408,730
2025-12-02 2025-12-02 PrS Proposed sale
3.6
Mackin James P

Officer; Director

Executive Director
30,921
46.27
US$1,430,715 		30,921 46.27 US$1,430,715
2025-11-24 2025-11-21 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
8,370 -15.8%
45.35
US$379,538 		8,370 -15.8% 45.35 US$379,538
2025-11-24 2025-11-21 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
18,705 -26.0%
44.91
US$840,042 		18,705 -26.0% 44.91 US$840,042
2025-11-24 2025-11-21 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
5,715 -11.3%
45.35
US$259,152 		5,715 -11.3% 45.35 US$259,152
2025-11-24 2025-11-21 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
14,586 -22.4%
44.92
US$655,189 		14,586 -22.4% 44.92 US$655,189
Explore more

More insider trading research around Artivion Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America